Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FJE83
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,886
Award facts
- Contract value 100% obligated
- $30,886.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,886.37 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a TNF inhibitor biologic medication used to treat autoimmune conditions. The contract was competitively awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, utilizing firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems' ongoing pharmaceutical requirements. The contract represents a routine transaction within AmerisourceBergen's established relationship with DLA, demonstrating the vendor's capability to meet federal procurement requirements through open competition and its status as a prime contractor for military medical supply operations.
Quick answers
Who was awarded contract SPE2DB25FJE83?
SPE2DB25FJE83 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FJE83 worth?
The government has obligated $30,886 on SPE2DB25FJE83.
Is contract SPE2DB25FJE83 an order under another contract?
Yes. SPE2DB25FJE83 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJE83 competed?
The extent of competition for SPE2DB25FJE83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award